Pharmaceuticals

Citi Pharma enters into joint venture to establish API, formulation facility in Saudi Arabia

Ferozsons strikes deal with Gilead Sciences to produce generic HIV drug 

BF Bioscience, pharma company owned by Ferozsons and Argentinian Bago Group, got a stellar response to its IPO. What lies ahead? 

Citi Pharma gets FDA nod to start exporting nutraceuticals to the United States

BF Biosciences expands production, launches diabetes treatment, secures listing approval

PPMA strongly refutes allegations against quality of Pakistani medicines

Pharmaceutical exports surge by 30% in July 2024

In the first quarter after deregulation, pharma sector revenue up by 25%

Ferozsons launches biologic to treat diabetes

Ferozsons subsidiary launches human insulin

BF Biosciences plans to raise Rs 1.37 billion through IPO 

Searle to sell its entire shareholding in Pakistani subsidiary  

Citi Pharma enters into supply agreement with India’s Murli Krishna Pharma 

CCP approves acquisition of two Japanese pharma products by Hilton Pharma

Sales tax hike to 18% expected to raise medicine prices

Hoechst Pakistan to acquire products and trademarks from Sanofi affiliates

Lucky Core seals deal for Pfizer's Karachi plant, pharma products

Searle Company to divest entire stake in Searle Pakistan Limited

Previous1234567Next